Solventum Corp

SOLV 10-K · Q4 2025
API behind this page

SOLV Q4 2025 request

Playground key active
Request URL /api/financials?ticker=SOLV&year=2025&quarter=4
waiting 0 ms 
Pick an endpoint and run the request.
curl

Income Statement

JSON CSV Excel
Income Statement
Metric Q4 2025 Q4 2024 YoY
Revenue 1,998 2,075 -3.7%
Show Product Lines breakouts
Cost of software and rentals 508 493 +3.0%
Product 1,490 1,582 -5.8%
Product · After Spin-Off 14 23 -39.1%
Show Business Segments breakouts
Dental Solutions · Operating Segments 343 316 +8.5%
Health Information Systems · Operating Segments 348 335 +3.9%
MedSurg · Advanced Wound Care 483 466 +3.6%
MedSurg · Infection Prevention and Surgical Solutions 752 709 +6.1%
MedSurg · Operating Segments 1,236 1,174 +5.3%
Purification and Filtration · Operating Segments 0 177 -100.0%
Show Consolidation Items breakouts
Corporate Non Segment 72 72 0.0%
Operating Segments 1,926 1,825 +5.5%
Show Related Party Transactions By Related Party breakouts
Related Party 14 23 -39.1%
Cost of Revenue (Q) — — —
Show Product Lines breakouts
Cost of software and rentals 116 125 -7.2%
Product 855 831 +2.9%
Product · After Spin-Off 135 156 -13.5%
Show Related Party Transaction breakouts
Master Supply Agreements · Related Party 56 60 -6.7%
Show Related Party Transactions By Related Party breakouts
Related Party 10 17 -41.2%
Gross Profit 1,027 1,119 -8.2%
Selling, General & Administrative 759 784 -3.2%
Show Related Party Transaction breakouts
After Spin-Off · Related Party 56 67 -16.4%
Research & Development 175 199 -12.1%
Show Related Party Transaction breakouts
After Spin-Off · Related Party 3 3 0.0%
Operating Income 124 136 -8.8%
Show Business Segments breakouts
Dental Solutions · Operating Segments 84 73 +15.1%
Health Information Systems · Operating Segments 133 114 +16.7%
MedSurg · Operating Segments 191 209 -8.6%
Purification and Filtration · Operating Segments 0 12 -100.0%
Show Consolidation Items breakouts
Corporate Non Segment 11 6 +83.3%
Operating Segments 408 396 +3.0%
Interest Income Expense Nonoperating Net 51 107 -52.3%
Other Non-Operating Income (Expense) 15 16 -6.2%
Income Before Taxes 58 13 +346.2%
Income Tax Expense (Benefit) -5 -17 +70.6%
Net Income 63 31 +103.2%
Show Equity Components breakouts
Retained Earnings 63 31 +103.2%
EPS (Basic) 0.36 0.18 +100.0%
EPS (Diluted) 0.35 0.18 +94.4%
Wtd Avg Shares (Basic) 0.1 0.1 0.0%
Wtd Avg Shares (Diluted) 0.2 0.3 -33.3%
Cost of Revenue (Q) — — —
Show Business Segments breakouts
Dental Solutions · Operating Segments 125 105 +19.0%
Health Information Systems · Operating Segments 82 92 -10.9%
MedSurg · Operating Segments 658 558 +17.9%
Total Costs & Expenses (Q) — — —
Show Related Party Transaction breakouts
Transition Agreement Services · Related Party 117 138 -15.2%
Operating Expenses (Q) — — —
Show Business Segments breakouts
Dental Solutions · Operating Segments 134 137 -2.2%
Health Information Systems · Operating Segments 132 128 +3.1%
MedSurg · Operating Segments 385 408 -5.6%
Comprehensive Income 41 -261 +115.7%
Other Comprehensive Income -22 -292 +92.5%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment -32 -25 -28.0%
Accumulated Gain Loss Net Cash Flow Hedge Parent 4 30 -86.7%
Accumulated Other Comprehensive Income -22 -292 +92.5%
Accumulated Translation Adjustment 6 -297 +102.0%
Operating Lease Lease Income 159 158 +0.6%

Balance Sheet

Balance Sheet
Metric Q4 2025 Q4 2024 YoY
Current Assets
Cash & Cash Equivalents 878 762 +15.2%
Accounts Receivable 1,034 1,044 -1.0%
Other Receivables Net Current 150 185 -18.9%
Inventory Finished Goods Net Of Reserves 636 539 +18.0%
Inventory Work In Process Net Of Reserves 201 190 +5.8%
Inventory Raw Materials And Supplies Net Of Reserves 229 236 -3.0%
Inventory 1,066 965 +10.5%
Other Assets Current 731 293 +149.5%
Total Current Assets 3,859 3,249 +18.8%
Non-Current Assets
Property, Plant & Equipment 1,326 1,622 -18.2%
Goodwill 5,704 6,377 -10.6%
Show Business Segments breakouts
Dental Solutions · Operating Segments 477 439 +8.7%
Health Information Systems · Operating Segments 873 871 +0.2%
MedSurg · Operating Segments 4,246 3,597 +18.0%
Show Consolidation Items breakouts
Corporate Non Segment 108 — —
Other Non-Current Assets 814 665 +22.4%
Total Assets 14,294 14,457 -1.1%
Operating Lease Right-of-Use Assets 214 176 +21.6%
Other Assets
Intangible Assets Net Excluding Goodwill 2,592 2,544 +1.9%
Current Liabilities
Accounts Payable 687 618 +11.2%
Accrued Liabilities 435 272 +59.9%
Deferred Revenue (Current) 621 572 +8.6%
Other Liabilities Current 1,393 1,041 +33.8%
Total Current Liabilities 3,136 2,703 +16.0%
Non-Current Liabilities
Long-Term Debt 5,035 7,810 -35.5%
Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent 363 350 +3.7%
Show Retirement Plan Type breakouts
Other Postretirement Benefit Plans Defined Benefit 123 117 +5.1%
Pension Plans Defined Benefit · Foreign Plan 107 155 -31.0%
Pension Plans Defined Benefit · US 125 70 +78.6%
Deferred Tax Liabilities 164 225 -27.1%
Other Non-Current Liabilities 547 410 +33.4%
Total Liabilities 9,245 11,498 -19.6%
Long-Term Debt 5,035 8,010 -37.1%
Show Debt Instrument breakouts
5.40% Senior Notes Due 2029 · Senior Notes 698 1,487 -53.1%
5.45% Senior Notes Due 2027 · Senior Notes 349 995 -64.9%
5.45% Senior Notes Due 2031 · Senior Notes 991 990 +0.1%
5.60% Senior Notes Due 2034 · Senior Notes 1,636 1,636 0.0%
5.90% Senior Notes Due 2054 · Senior Notes 1,209 1,231 -1.8%
6.00% Senior Notes Due 2064 · Senior Notes 42 492 -91.5%
Credit Facilities · Three year senior term loan credit facility 110 979 -88.8%
Operating Lease Liabilities 142 86 +65.1%
Stockholders' Equity
Common Stock 2 2 0.0%
Additional Paid-In Capital 3,876 3,771 +2.8%
Retained Earnings 1,797 242 +642.6%
Accumulated Other Comprehensive Income -625 -1,056 +40.8%
Total Stockholders' Equity 5,049 2,959 +70.6%
Show Equity Components breakouts
Accumulated Defined Benefit Plans Adjustment -488 -526 +7.2%
Accumulated Gain Loss Net Cash Flow Hedge Parent -8 20 -140.0%
Accumulated Other Comprehensive Income -625 -1,056 +40.8%
Accumulated Translation Adjustment -130 -550 +76.4%
Additional Paid In Capital 3,876 3,771 +2.8%
Common Stock 2 2 0.0%
Retained Earnings 1,797 242 +642.6%
Total Liabilities & Equity 14,294 14,457 -1.1%

Cash Flow Statement

Cash Flow Statement
Metric YTD Q4 2025 YTD Q4 2024 YoY
Operating Activities
Depreciation & Amortization 117 150 -22.0%
Pension And Other Postretirement Benefits Expense Reversal Of Expense Noncash 13 4 +225.0%
Stock-Based Compensation 37 25 +48.0%
Deferred Income Taxes -73 -62 -17.7%
Change in Accounts Receivable -2 29 -106.9%
Increase Decrease In Due From Related Parties 7 33 -78.8%
Change in Inventory -5 -33 +84.8%
Change in Accounts Payable 30 66 -54.5%
Increase Decrease In Due To Related Parties -29 -74 +60.8%
Increase Decrease In Accrued Salaries 52 25 +108.0%
Other Operating Activities Cash Flow Statement -59 25 -336.0%
Net Cash from Operations 95 219 -56.6%
Investing Activities
Capital Expenditures -63 -127 +50.4%
Net Cash from Investing -745 -127 -486.6%
Financing Activities
Debt Repayments -100 -100 0.0%
Payments For Proceeds From Parent -12 -4 -200.0%
Show Related Party Transactions By Related Party breakouts
Related Party -12 -4 -200.0%
Proceeds From Payments For Other Financing Activities -3 0 —
Net Cash from Financing -115 -104 -10.6%
Other Cash Flow
Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations 1 2 -50.0%
Net Change in Cash -764 -10 -7540.0%
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents 878 762 +15.2%

Values in millions USD. Source: SEC EDGAR 10-K filing.

This table is rendered from the same JSON returned by /api/financials.

Get API Key